DAFTAR PUSTAKA Potensi Interaksi Obat Pada Pasien Asma Rawat Inap Di Rsud Dr. Moewardi Tahun 2014.
33
DAFTAR PUSTAKA
Akinbami, L.J., Moorman, J.E., Bailey, C., Zahran, H.S., King, M., Johnson,
C.A., Liu, X., 2012. Trends in Asthma Prevalence, Health Care Use, and
Mortality in the United States, 2001-2010. Natlional Center Health
Statatistics.
Amirav, I., Amitai, Y., Avital, A., Godfrey, S., 1998. Enhancement of
Theophylline Clearance by Intravenous Albuterol. Chest 94, 444–445.
Ansari, J.A., 2010. Drug interaction and pharmacist. Journal of Young
Pharmacists 2, 326–331.
Aronson, J.K., 2004. Classifying drug interactions. British Journal of Clinical
Pharmacology 58, 343–344.
Barclay, J., Whiting, B., Meredith, P., Addis, G., 1981. Theophylline-salbutamol
interaction: bronchodilator response to salbutamol at maximally effective
plasma theophylline concentrations. British Journal of Clinical
Pharmacology 11, 203–208.
Baxter, K. (Ed.), 2008. Stockley’s Drug Interactions. Pharmaceutical Press,
London, p. 1099.
Becker, M.L., Kallewaard, M., Caspers, P.W.J., Schalekamp, T., Stricker, B.H.C.,
2005. Potential Determinants of Drug-Drug Interaction Associated
Dispensing in Community Pharmacies. Drug Safety 28, 371–378.
Boehning, W., 1990. Effect of cimetidine and ranitidine on plasma theophylline in
patients with chronic obstructive airways disease treated with theophylline
and corticosteroids. European Journal of Clinical Pharmacology 38, 43–5.
Burnakis, T.G., Mioduch, H.J., 1984. Combined therapy with captopril and
potassium supplementation. A potential for hyperkalemia. Archives of
Internal Medicine 144, 2371–2.
Chan, T.Y., Critchley, J.A., 1992. Life-threatening hyperkalaemia in an elderly
patient receiving captopril, furosemide (frusemide) and potassium
supplements. Drug Safety 7, 159–61.
Chow, O.K.W., Fung, K.P., 1989. Slow-Release Terbutaline and Theophylline for
the Long-Term Therapy of Children With Asthma: A Latin Square and
Factorial Study of Drug Effects and Interactions. Pediatrics 84, 119–125.
Departemen Kesehatan RI, 2007. Pharmaceutical Care Untuk Penyakit Asma.
Departemen Kesehatan RI, Jakarta.
Departemen Kesehatan RI, 2009. Pedoman Pengendalian Penyakit Asma.
Departemen Kesehatan RI, Jakarta.
34
Edisworo, M.W., 2009. Hubungan Tingkat Pengetahuan Umum Asma dengan
Tingkat Kontrol Asma di Poliklinik Asma Rumah Sakit Persahabatan
Jakarta. Skripsi. Fakultas Kedokteran Universitas Indonsesia.
Farrokhnia, F., Arbabi, S., 2008. Effects of oral methylprednisolone and inhaled
salbutamol in the decrease of wheezing in patients with asthma after tracheal
intubation. DARU Journal of Pharmaceutical Science 16, 164–168.
Fergusson, R.J., Scott, C.M., Rafferty, P., Gaddie, J., 1987. Effect of prednisolone
on theophylline pharmacokinetics in patients with chronic airflow
obstruction. Thorax 42, 195–198.
Fost, D.A., Leung, D.Y.. ., Martin, R.J., Brown, E.E., Szefler, S.J., Spahn, J.D.,
1999. Inhibition of methylprednisolone elimination in the presence of
clarithromycin therapy. Journal of Allergy and Clinical Immunology 103,
1031–1035.
Gillissen, A., 2004. Managing asthma in the real world. International Journal of
Clinical Practice 58, 592–603.
GINA, 2011. Pocket Guide for Asthma Management. Global Initiative For
Asthma.
Hart, S.P., 2000. Should aminophylline be abandoned in the treatment of acute
asthma in adults?. Quarterly Journal of Medicine 93, 761–5.
Hasan, S.S., Lim, K.N., Anwar, M., Sathvik, B.S., Ahmadi, K., Yuan, A.W.L.,
Kamarunnesa, M.A., 2012. Impact of pharmacists’ intervention on
identification and management of drug-drug interactions in an intensive care
setting. Singapore Medical Journal 53, 526–31.
Hashem, G., 2005. Drug – Drug Interactions, Medicine. Cairo.
Jonas, D.E., Wines, R.C.M., 2011. Drug Class Review Controller Medications for
Asthma. Drug Class Reviews, 1–369.
Juurlink, D.N., Mamdani, M., Kopp, A., Laupacis, A., Redelmeier, D.A., 2003.
Drug-drug interactions among elderly patients hospitalized for drug toxicity.
The Journal of the American Medical Association 289, 1652–1658.
Khaliq, Y., Zhanel, G.G., 2003. Fluoroquinolone-associated tendinopathy: a
critical review of the literature. Clinical Infectious Diseases 36, 1404–10.
Kigen, G., Kimaiyo, S., Owen, A., Edwards, G., Back, D., Gibbons, S., Sang, E.,
Khoo, S., 2008. Prevalence of Drug Interactions Between Antiretroviral and
Co-administered Drugs in Kenya Developed countries. Journal of Clinical
Pharmacy Therapeutics.
Kynyk, J.A., Mastronarde, J.G., McCallister, J.W., 2011. Asthma, the Sex
Difference. Current Opinion in Pulmonary Medicine 17, 6–11.
35
Leynaert, B., Sunyer, J., Garcia-Esteban, R., Svanes, C., Jarvis, D., Cerveri, I.,
Dratva, J., Gislason, T., Heinrich, J., Janson, C., Kuenzli, N., de Marco, R.,
Omenaas, E., Raherison, C., Gómez Real, F., Wjst, M., Zemp, E., Zureik,
M., Burney, P.G.J., Anto, J.M., Neukirch, F., 2012. Gender differences in
prevalence, diagnosis and incidence of allergic and non-allergic asthma: a
population-based cohort. Thorax 67, 625–31.
Littenberg, B., 1988. Aminophylline treatment in severe, acute asthma: A metaanalysis. The Journal of American Medical Association 259, 1678–1684.
Masoli, M., Fabian, D., Holt, S., Beasley, R., 2004. Developed for the Global
Initiative for Asthma. Global Initiative for Asthma 1–122.
NAEPP, 2007. Guidelines for the Diagnosis and Management of Asthma. Journal
of Allergy and Clinical Immunology 120, 28–29.
Nakajima, M., Suzuki, T., Sasaki, T., Yokoi, T., Hosoyamada, A., Yamamoto, T.,
Kuroiwa, Y., 1999. Effects of chronic administration of glucocorticoid on
midazolam pharmacokinetics in humans. Therapeutic Drug Monitoring 21,
507–13.
National Institute of Health, 2011. Asthma Care Quick Reference: Diagnosing and
Managing Asthma. National Institute of Health US Department of Health
and Human Service.
Nelson, S.D., 2008. Drug-Drug Interactions. In: Rodrigues, D.A. (Ed.), DrugDrug Interactions. Drug and The Pharmaceutical Sciences, New Jersey, p.
690.
Nishimuta, T., Kondo, N., Hamasaki, Y., Morikawa, A., Nishima, S., 2011.
Japanese guideline for childhood asthma. Allergology International 60, 147–
169.
Pearce, N., Strachan, D., 2011. The Global Asthma Report 2011. Paris, France:
The International Union Against Tuberculosis and Lung Disease. The
International Study of Asthma and Allergies in Childhood, 76.
Rengganis, I., 2008. Diagnosis dan Tatalaksana Asma Bronkial. Majalah
Kedokteran Indonesia, 58.
Rivianti, C., 2010. Tinjauan Interaksi Obat Pada Pasien Asma di INstalasi Rawat
Inap Rumah Sakit Roemani Muhammadiyah Semarang Periode Maret 2008Maret 2010. Skripsi. Fakultas Farmasi Universitas Muhammadiyah
Surakarta.
Roy, A.K., Cuda, M.P., Levine, R.A., 1988. Induction of theophylline toxicity and
inhibition of clearance rates by ranitidine. The American Journal of Medicine
85, 525–7.
36
Snyder, B.D., Polasek, T.M., Doogue, M.P., 2012. Drug interactions: principles
and practice. Australian Presciber 35, 85–88.
Spivey, J.M., Laughlin, P.H., Goss, T.F., Nix, D.E., 2016. Theophylline toxicity
secondary to ciprofloxacin administration. Annals of Emergency Medicine
20, 1131–1134.
Subbarao, P., Mandhane, P.J., Sears, M.R., 2009. Asthma: epidemiology, etiology
and risk factors. Canadian Medical Association Journal 181, E181–190.
Sundaru, H., 2001. Buku Ajar Ilmu Penyakit Dalam, 3th ed. Balai Penerbit
Fakultas Kedokteran Univeritas Indonesia, Jakarta.
Svedmyr, K., Lofdahl, C.-G., Svedmyr, N., 1984. Nifedipine - a Calcium Channel
Blocker - in Asthmatic Patients Interaction with Terbutaline. Allergy 39, 17–
22.
Takarabe, M., Shigemizu, D., Goto, S., Kotera, M., Kanehisa, M., 2010.
Characterization and Classification of Adverse Drug. Journal of Genome
Inform, 167–175.
Tatro, D.S., 2012. Drug Interaction Facts 2012: The Authority on Drug
Interactions. Wolters Kluwer Health, California.
Taylor, D.R., 2000. Interactions between corticosteroids and beta agonists. Thorax
55, 595–602.
Villikka, K., Varis, T., Backman, J.T., Neuvonen, P.J., Kivistö, K.T., 2001. Effect
of methylprednisolone on CYP3A4-mediated drug metabolism in vivo.
European Journal of Clinical Pharmacology 57, 457–60.
WHO, 2002. Prevention of Allergy and Allergic Asthma. Management of
Noncommunicable Diseases Departement, 8–9.
Wijnands, W.J., Vree, T.B., 1988. Interaction between the fluoroquinolones and
the bronchodilator theophylline. The Journal of Antimicrobial Chemotherapy
22 Suppl C, 109–14.
DAFTAR PUSTAKA
Akinbami, L.J., Moorman, J.E., Bailey, C., Zahran, H.S., King, M., Johnson,
C.A., Liu, X., 2012. Trends in Asthma Prevalence, Health Care Use, and
Mortality in the United States, 2001-2010. Natlional Center Health
Statatistics.
Amirav, I., Amitai, Y., Avital, A., Godfrey, S., 1998. Enhancement of
Theophylline Clearance by Intravenous Albuterol. Chest 94, 444–445.
Ansari, J.A., 2010. Drug interaction and pharmacist. Journal of Young
Pharmacists 2, 326–331.
Aronson, J.K., 2004. Classifying drug interactions. British Journal of Clinical
Pharmacology 58, 343–344.
Barclay, J., Whiting, B., Meredith, P., Addis, G., 1981. Theophylline-salbutamol
interaction: bronchodilator response to salbutamol at maximally effective
plasma theophylline concentrations. British Journal of Clinical
Pharmacology 11, 203–208.
Baxter, K. (Ed.), 2008. Stockley’s Drug Interactions. Pharmaceutical Press,
London, p. 1099.
Becker, M.L., Kallewaard, M., Caspers, P.W.J., Schalekamp, T., Stricker, B.H.C.,
2005. Potential Determinants of Drug-Drug Interaction Associated
Dispensing in Community Pharmacies. Drug Safety 28, 371–378.
Boehning, W., 1990. Effect of cimetidine and ranitidine on plasma theophylline in
patients with chronic obstructive airways disease treated with theophylline
and corticosteroids. European Journal of Clinical Pharmacology 38, 43–5.
Burnakis, T.G., Mioduch, H.J., 1984. Combined therapy with captopril and
potassium supplementation. A potential for hyperkalemia. Archives of
Internal Medicine 144, 2371–2.
Chan, T.Y., Critchley, J.A., 1992. Life-threatening hyperkalaemia in an elderly
patient receiving captopril, furosemide (frusemide) and potassium
supplements. Drug Safety 7, 159–61.
Chow, O.K.W., Fung, K.P., 1989. Slow-Release Terbutaline and Theophylline for
the Long-Term Therapy of Children With Asthma: A Latin Square and
Factorial Study of Drug Effects and Interactions. Pediatrics 84, 119–125.
Departemen Kesehatan RI, 2007. Pharmaceutical Care Untuk Penyakit Asma.
Departemen Kesehatan RI, Jakarta.
Departemen Kesehatan RI, 2009. Pedoman Pengendalian Penyakit Asma.
Departemen Kesehatan RI, Jakarta.
34
Edisworo, M.W., 2009. Hubungan Tingkat Pengetahuan Umum Asma dengan
Tingkat Kontrol Asma di Poliklinik Asma Rumah Sakit Persahabatan
Jakarta. Skripsi. Fakultas Kedokteran Universitas Indonsesia.
Farrokhnia, F., Arbabi, S., 2008. Effects of oral methylprednisolone and inhaled
salbutamol in the decrease of wheezing in patients with asthma after tracheal
intubation. DARU Journal of Pharmaceutical Science 16, 164–168.
Fergusson, R.J., Scott, C.M., Rafferty, P., Gaddie, J., 1987. Effect of prednisolone
on theophylline pharmacokinetics in patients with chronic airflow
obstruction. Thorax 42, 195–198.
Fost, D.A., Leung, D.Y.. ., Martin, R.J., Brown, E.E., Szefler, S.J., Spahn, J.D.,
1999. Inhibition of methylprednisolone elimination in the presence of
clarithromycin therapy. Journal of Allergy and Clinical Immunology 103,
1031–1035.
Gillissen, A., 2004. Managing asthma in the real world. International Journal of
Clinical Practice 58, 592–603.
GINA, 2011. Pocket Guide for Asthma Management. Global Initiative For
Asthma.
Hart, S.P., 2000. Should aminophylline be abandoned in the treatment of acute
asthma in adults?. Quarterly Journal of Medicine 93, 761–5.
Hasan, S.S., Lim, K.N., Anwar, M., Sathvik, B.S., Ahmadi, K., Yuan, A.W.L.,
Kamarunnesa, M.A., 2012. Impact of pharmacists’ intervention on
identification and management of drug-drug interactions in an intensive care
setting. Singapore Medical Journal 53, 526–31.
Hashem, G., 2005. Drug – Drug Interactions, Medicine. Cairo.
Jonas, D.E., Wines, R.C.M., 2011. Drug Class Review Controller Medications for
Asthma. Drug Class Reviews, 1–369.
Juurlink, D.N., Mamdani, M., Kopp, A., Laupacis, A., Redelmeier, D.A., 2003.
Drug-drug interactions among elderly patients hospitalized for drug toxicity.
The Journal of the American Medical Association 289, 1652–1658.
Khaliq, Y., Zhanel, G.G., 2003. Fluoroquinolone-associated tendinopathy: a
critical review of the literature. Clinical Infectious Diseases 36, 1404–10.
Kigen, G., Kimaiyo, S., Owen, A., Edwards, G., Back, D., Gibbons, S., Sang, E.,
Khoo, S., 2008. Prevalence of Drug Interactions Between Antiretroviral and
Co-administered Drugs in Kenya Developed countries. Journal of Clinical
Pharmacy Therapeutics.
Kynyk, J.A., Mastronarde, J.G., McCallister, J.W., 2011. Asthma, the Sex
Difference. Current Opinion in Pulmonary Medicine 17, 6–11.
35
Leynaert, B., Sunyer, J., Garcia-Esteban, R., Svanes, C., Jarvis, D., Cerveri, I.,
Dratva, J., Gislason, T., Heinrich, J., Janson, C., Kuenzli, N., de Marco, R.,
Omenaas, E., Raherison, C., Gómez Real, F., Wjst, M., Zemp, E., Zureik,
M., Burney, P.G.J., Anto, J.M., Neukirch, F., 2012. Gender differences in
prevalence, diagnosis and incidence of allergic and non-allergic asthma: a
population-based cohort. Thorax 67, 625–31.
Littenberg, B., 1988. Aminophylline treatment in severe, acute asthma: A metaanalysis. The Journal of American Medical Association 259, 1678–1684.
Masoli, M., Fabian, D., Holt, S., Beasley, R., 2004. Developed for the Global
Initiative for Asthma. Global Initiative for Asthma 1–122.
NAEPP, 2007. Guidelines for the Diagnosis and Management of Asthma. Journal
of Allergy and Clinical Immunology 120, 28–29.
Nakajima, M., Suzuki, T., Sasaki, T., Yokoi, T., Hosoyamada, A., Yamamoto, T.,
Kuroiwa, Y., 1999. Effects of chronic administration of glucocorticoid on
midazolam pharmacokinetics in humans. Therapeutic Drug Monitoring 21,
507–13.
National Institute of Health, 2011. Asthma Care Quick Reference: Diagnosing and
Managing Asthma. National Institute of Health US Department of Health
and Human Service.
Nelson, S.D., 2008. Drug-Drug Interactions. In: Rodrigues, D.A. (Ed.), DrugDrug Interactions. Drug and The Pharmaceutical Sciences, New Jersey, p.
690.
Nishimuta, T., Kondo, N., Hamasaki, Y., Morikawa, A., Nishima, S., 2011.
Japanese guideline for childhood asthma. Allergology International 60, 147–
169.
Pearce, N., Strachan, D., 2011. The Global Asthma Report 2011. Paris, France:
The International Union Against Tuberculosis and Lung Disease. The
International Study of Asthma and Allergies in Childhood, 76.
Rengganis, I., 2008. Diagnosis dan Tatalaksana Asma Bronkial. Majalah
Kedokteran Indonesia, 58.
Rivianti, C., 2010. Tinjauan Interaksi Obat Pada Pasien Asma di INstalasi Rawat
Inap Rumah Sakit Roemani Muhammadiyah Semarang Periode Maret 2008Maret 2010. Skripsi. Fakultas Farmasi Universitas Muhammadiyah
Surakarta.
Roy, A.K., Cuda, M.P., Levine, R.A., 1988. Induction of theophylline toxicity and
inhibition of clearance rates by ranitidine. The American Journal of Medicine
85, 525–7.
36
Snyder, B.D., Polasek, T.M., Doogue, M.P., 2012. Drug interactions: principles
and practice. Australian Presciber 35, 85–88.
Spivey, J.M., Laughlin, P.H., Goss, T.F., Nix, D.E., 2016. Theophylline toxicity
secondary to ciprofloxacin administration. Annals of Emergency Medicine
20, 1131–1134.
Subbarao, P., Mandhane, P.J., Sears, M.R., 2009. Asthma: epidemiology, etiology
and risk factors. Canadian Medical Association Journal 181, E181–190.
Sundaru, H., 2001. Buku Ajar Ilmu Penyakit Dalam, 3th ed. Balai Penerbit
Fakultas Kedokteran Univeritas Indonesia, Jakarta.
Svedmyr, K., Lofdahl, C.-G., Svedmyr, N., 1984. Nifedipine - a Calcium Channel
Blocker - in Asthmatic Patients Interaction with Terbutaline. Allergy 39, 17–
22.
Takarabe, M., Shigemizu, D., Goto, S., Kotera, M., Kanehisa, M., 2010.
Characterization and Classification of Adverse Drug. Journal of Genome
Inform, 167–175.
Tatro, D.S., 2012. Drug Interaction Facts 2012: The Authority on Drug
Interactions. Wolters Kluwer Health, California.
Taylor, D.R., 2000. Interactions between corticosteroids and beta agonists. Thorax
55, 595–602.
Villikka, K., Varis, T., Backman, J.T., Neuvonen, P.J., Kivistö, K.T., 2001. Effect
of methylprednisolone on CYP3A4-mediated drug metabolism in vivo.
European Journal of Clinical Pharmacology 57, 457–60.
WHO, 2002. Prevention of Allergy and Allergic Asthma. Management of
Noncommunicable Diseases Departement, 8–9.
Wijnands, W.J., Vree, T.B., 1988. Interaction between the fluoroquinolones and
the bronchodilator theophylline. The Journal of Antimicrobial Chemotherapy
22 Suppl C, 109–14.